Finance

Lists
HCWB:NASDAQ
Hcw Biologics Inc
$2.82
+5.22%
(+0.14) 1D
Aug 17, 10:11:39 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCWB...
Open
$2.68
High
$2.82
Low
$2.65
Mkt. cap
4.54M
Avg. vol.
65.51K
Volume
9.94K
52-wk high
$44.10
52-wk low
$1.51
EPS
-$56.72
Beta
2.32
Shares outstanding
1.60M
No. of employees
35
Open
$2.68
High
$2.82
Low
$2.65
Mkt. cap
4.54M
Avg. vol.
65.51K
Volume
9.94K
52-wk high
$44.10
52-wk low
$1.51
EPS
-$56.72
Beta
2.32
Shares outstanding
1.60M
No. of employees
35
News stories
From web sources and news partners
About Hcw Biologics Inc
CEO-
Employees35
Founded2018
HeadquartersMiramar, Florida, United States
SectorBiotechnology
Websitehcwbiologics.com
Analyst ratings
Based on 1 analyst giving stock ratings to HCWB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for HCWB in the last 3 months
Highest
Current $2.82
$5.00 (+77.31%)
Average
$5.00 (+77.31%)
Lowest
$5.00 (+77.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$5.00
+77.3%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.61K
27.01K
6.54M
135.57K
Cost of goods sold
12.48K
21.61K
11.07K
229.46K
Cost of revenue
12.48K
21.61K
11.07K
229.46K
Research and development expenses
1.38M
1.31M
1.23M
1.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.92M
3.66M
1.87M
1.87M
Operating expense
3.30M
4.97M
3.30M
3.07M
Total operating expenses
3.31M
4.99M
3.31M
3.30M
Operating income
-3.29M
-4.96M
3.24M
-3.17M
Other non operating income
-168.86K
-67.86K
676.23K
-2.44M
EBT including unusual items
-4.55M
719.23K
3.80M
-5.22M
EBT excluding unusual items
-3.59M
-5.24M
3.80M
-5.70M
Income tax expense
-
-
330.19K
-
Effective tax rate
-
-
8.68%
-
Other operating expenses
-
-
198.15K
-
Net income
-4.55M
719.23K
3.47M
-5.22M
Net profit margin
-29,183.24%
2,662.84%
53.07%
-3,849.90%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-127.07K
-212.13K
-109.27K
-100.54K
Net interest expenses
-127.07K
-212.13K
-109.27K
-100.54K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.12M
-4.80M
3.38M
-3.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps